Literature DB >> 32020980

Interferon alpha: A rare cause of persistent pulmonary hypertension of newborn.

Hardeep Kaur1, Harish Sethi2, Gaurav Mahajan3.   

Abstract

Entities:  

Keywords:  Interferon alpha; Newborn; Persistent pulmonary hypertension

Year:  2018        PMID： 32020980      PMCID： PMC6994731          DOI： 10.1016/j.mjafi.2017.12.010

Source DB:  PubMed          Journal:  Med J Armed Forces India        ISSN： 0377-1237


× No keyword cloud information.
  9 in total

1.  Interferon-alpha elevates pulmonary blood pressure in sheep--the role of thromboxane cascade.

Authors:  M Hanaoka; K Kubo; T Hayano; T Koizumi; T Kobayashi
Journal:  Eur J Pharmacol       Date:  1999-04-09       Impact factor: 4.432

2.  Severe exacerbation of asthma: a new side effect of interferon-alpha in patients with asthma and chronic hepatitis C.

Authors:  E J Bini; E H Weinshel
Journal:  Mayo Clin Proc       Date:  1999-04       Impact factor: 7.616

3.  Pleural effusion during interferon treatment for chronic hepatitis C.

Authors:  A Takeda; K Ikegame; Y Kimura; H Ogawa; S Kanazawa; H Nakamura
Journal:  Hepatogastroenterology       Date:  2000 Sep-Oct

4.  Interferon-related bronchiolitis obliterans organizing pneumonia.

Authors:  K Ogata; T Koga; K Yagawa
Journal:  Chest       Date:  1994-08       Impact factor: 9.410

Review 5.  Pathophysiologic mechanisms of persistent pulmonary hypertension of the newborn.

Authors:  S Dakshinamurti
Journal:  Pediatr Pulmonol       Date:  2005-06

6.  Molecular heterogeneity in complete cytogenetic responders after interferon-alpha therapy for chronic myelogenous leukemia: low levels of minimal residual disease are associated with continuing remission. German CML Study Group and the UK MRC CML Study Group.

Authors:  A Hochhaus; A Reiter; S Saussele; A Reichert; M Emig; J Kaeda; B Schultheis; U Berger; P C Shepherd; N C Allan; R Hehlmann; J M Goldman; N C Cross
Journal:  Blood       Date:  2000-01-01       Impact factor: 22.113

7.  Irreversible pulmonary hypertension associated with the use of interferon alpha for chronic hepatitis C.

Authors:  Sonu Dhillon; Anshul Kaker; Aneil Dosanjh; Deepa Japra; David H Vanthiel
Journal:  Dig Dis Sci       Date:  2010-04-22       Impact factor: 3.199

8.  Selective serotonin-reuptake inhibitors and risk of persistent pulmonary hypertension of the newborn.

Authors:  Christina D Chambers; Sonia Hernandez-Diaz; Linda J Van Marter; Martha M Werler; Carol Louik; Kenneth Lyons Jones; Allen A Mitchell
Journal:  N Engl J Med       Date:  2006-02-09       Impact factor: 91.245

9.  Long-term therapy of interferon-alpha induced pulmonary arterial hypertension with different PDE-5 inhibitors: a case report.

Authors:  Nicoline Jochmann; Felix Kiecker; Adrian C Borges; Maja A Hofmann; Stephan Eddicks; Wolfram Sterry; Gert Baumann; Uwe Trefzer
Journal:  Cardiovasc Ultrasound       Date:  2005-09-02       Impact factor: 2.062
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.